$15,635.55 consulting Payment -- Pfizer Inc to Dr. Michael Rodriguez
Internal Medicine Physician Receives $15,635 Consulting Fee from Pfizer for Trulicity
This page provides a detailed analysis of a $15,635.55 consulting payment from Pfizer Inc to Dr. Michael Rodriguez. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $15,635.55 |
| Payment Type | consulting |
| Payment Nature | Consulting Fee |
| Pharmaceutical Company | Pfizer Inc |
| Physician | Dr. Michael Rodriguez |
| NPI Number | 1230238611 |
| Physician Specialty | Internal Medicine |
| Location | City, MO |
| Date of Payment | 2025-07-24 |
| Related Drug/Device | Trulicity |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Pfizer Inc made a $15.6K consulting payment to Michael Rodriguez, a Internal Medicine specialist in City, MO. The payment was associated with Trulicity. The payment of $15,635.55 to Dr. Michael Rodriguez from Pfizer Inc. for consulting services related to Trulicity is a significant amount for this type of engagement. The payment was made on July 24, 2025, indicating a recent engagement between the physician and the pharmaceutical company. Dr. Rodriguez, an Internal Medicine specialist, received this payment for consulting, suggesting his expertise was sought for product development or advisory roles.
Patient Guidance: What This Payment Means for You
If you are a patient being treated with Trulicity, your doctor may receive payments for consulting services to help improve medications and treatments. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
For Internal Medicine specialists, consulting fees from pharmaceutical companies can vary widely, but this amount is on the higher end for a single engagement.
Regulatory Context: Sunshine Act Requirements
Physicians are required to report payments received from pharmaceutical companies, including consulting fees, to the CMS Open Payments program to ensure transparency.
Related Topics
This payment is related to the following healthcare transparency topics:
- consulting-fee
- pharmaceutical-payments
- physician-compensation
- internal-medicine
- pfizer-inc
- trulicity
Understanding consulting Payments
Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.
Frequently Asked Questions About This Payment
What was this $15.6K payment for?
This was a consulting payment of $15.6K from Pfizer Inc to Michael Rodriguez, categorized as "Consulting Fee". It was associated with Trulicity. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Michael Rodriguez accept pharmaceutical money?
Yes, Michael Rodriguez received this $15.6K payment from Pfizer Inc. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Michael Rodriguez's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this consulting payment?
A consulting payment of $15.6K may reflect legitimate advisory services the physician provides. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Internal Medicine?
To compare this payment against Internal Medicine averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Internal Medicine physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Michael Rodriguez's relationship with Pfizer Inc?
The payment amount is substantial for a single consulting engagement. This $15.6K consulting payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Internal Medicine?
The payment type is specifically listed as a 'Consulting Fee'.
What should patients do after learning about this payment?
If you are a patient being treated with Trulicity, your doctor may receive payments for consulting services to help improve medications and treatments.
What else should I know about this consulting payment?
The drug associated with the payment is Trulicity, a known medication in the diabetes space.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.